Sharon Westerberg, PA-C

NPI: 1629097191
Total Payments
$13,846
2024 Payments
$4,243
Companies
63
Transactions
497

Payment Breakdown by Category

Food & Beverage$12,819 (92.6%)
Other$540.00 (3.9%)
Education$486.94 (3.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $12,819 491 92.6%
Honoraria $540.00 1 3.9%
Education $486.94 5 3.5%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,055 33 $0 (2024)
Incyte Corporation $1,010 41 $0 (2024)
Celgene Corporation $778.05 36 $0 (2024)
Karyopharm Therapeutics Inc. $761.24 6 $0 (2024)
Gilead Sciences, Inc. $735.63 20 $0 (2024)
Janssen Biotech, Inc. $727.10 30 $0 (2024)
Astellas Pharma US Inc $629.27 16 $0 (2024)
PFIZER INC. $566.51 28 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $562.60 17 $0 (2024)
E.R. Squibb & Sons, L.L.C. $462.16 14 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,243 154 Incyte Corporation ($367.00)
2023 $3,370 127 AstraZeneca Pharmaceuticals LP ($447.33)
2022 $3,193 119 Celgene Corporation ($344.62)
2021 $3,022 96 Karyopharm Therapeutics Inc. ($665.00)
2018 $18.52 1 APO-PHARMA USA, INC. ($18.52)

All Payment Transactions

497 individual payment records from CMS Open Payments — Page 1 of 20

Date Company Product Nature Form Amount Type
12/23/2024 Lilly USA, LLC VERZENIO (Drug), JAYPIRCA Food and Beverage In-kind items and services $20.38 General
Category: Oncology
12/19/2024 ABBVIE INC. ELAHERE (Drug) Food and Beverage In-kind items and services $27.76 General
Category: ONCOLOGY
12/18/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $21.35 General
Category: Oncology
12/17/2024 Geron Corporation RYTELO (Drug) Food and Beverage In-kind items and services $19.51 General
Category: MYELODYSPLASTIC SYNDROME
12/16/2024 Incyte Corporation PEMAZYRE (Drug), MONJUVI Food and Beverage Cash or cash equivalent $18.87 General
Category: Hepatology (Liver, Pancreatic, Gall Bladder)
12/16/2024 Incyte Corporation MONJUVI (Drug), PEMAZYRE Food and Beverage Cash or cash equivalent $2.23 General
Category: Oncology
12/10/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $34.72 General
Category: Oncology
12/06/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.57 General
12/05/2024 Astellas Pharma US Inc Vyloy (Drug) Food and Beverage In-kind items and services $133.29 General
Category: Oncology
12/05/2024 TAIHO ONCOLOGY, INC. LONSURF (Drug), INQOVI Food and Beverage In-kind items and services $17.75 General
Category: Oncology
12/04/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $19.62 General
Category: Oncology
12/02/2024 PUMA BIOTECHNOLOGY, INC. Food and Beverage In-kind items and services $27.97 General
12/02/2024 Takeda Pharmaceuticals U.S.A., Inc. FRUZAQLA (Drug) Food and Beverage In-kind items and services $24.45 General
Category: ONCOLOGY
11/27/2024 E.R. Squibb & Sons, L.L.C. OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $13.97 General
Category: Oncology
11/26/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $23.54 General
Category: Rare Disease
11/25/2024 Genentech USA, Inc. Itovebi (Biological), Phesgo Food and Beverage In-kind items and services $34.18 General
Category: BioOncology
11/21/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $18.52 General
Category: ONCOLOGY
11/18/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $25.53 General
Category: Immunology
11/15/2024 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $32.20 General
Category: ONCOLOGY
11/14/2024 BeiGene USA, Inc. TEVIMBRA (Drug) Food and Beverage In-kind items and services $34.55 General
Category: Oncology
11/12/2024 PharmaEssentia USA Corporation BESREMI (Drug) Food and Beverage In-kind items and services $27.80 General
Category: Oncology
11/08/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $22.41 General
Category: Oncology
11/05/2024 Bayer Healthcare Pharmaceuticals Inc. Stivarga (Drug) Food and Beverage In-kind items and services $17.08 General
Category: Oncology
11/04/2024 PUMA BIOTECHNOLOGY, INC. Food and Beverage In-kind items and services $28.43 General
11/01/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $25.81 General
Category: ONCOLOGY

About Sharon Westerberg, PA-C

Sharon Westerberg, PA-C is a Hematology & Oncology healthcare provider based in Anaheim, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629097191.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sharon Westerberg, PA-C has received a total of $13,846 in payments from pharmaceutical and medical device companies, with $4,243 received in 2024. These payments were reported across 497 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($12,819).

Practice Information

  • Specialty Hematology & Oncology
  • Location Anaheim, CA
  • Active Since 07/18/2006
  • Last Updated 03/18/2013
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1629097191

Products in Payments

  • XPOVIO (Drug) $761.24
  • Pomalyst (Drug) $548.01
  • Trodelvy (Drug) $497.94
  • JAKAFI (Drug) $481.79
  • Lenvima (Drug) $408.32
  • MONJUVI (Drug) $376.01
  • KEYTRUDA (Biological) $340.86
  • REBLOZYL (Biological) $339.60
  • CALQUENCE (Drug) $307.32
  • LIBTAYO (Biological) $286.72
  • DARZALEX (Biological) $281.91
  • LYNPARZA (Drug) $275.06
  • Nubeqa (Drug) $273.41
  • IBRANCE (Drug) $243.93
  • ADCETRIS (Biological) $230.41
  • VERZENIO (Drug) $223.59
  • ENHERTU (Biological) $200.75
  • BRUKINSA (Drug) $195.72
  • FRUZAQLA (Drug) $192.85
  • Udenyca (Biological) $192.06

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Anaheim